Target Details
| UniProt AC | P30556 |
|---|---|
| Gene Symbol | AGTR1 |
| Protein Name | Type-1 angiotensin II receptor |
| Organism | Homo sapiens |
| Entry Name | |
| Organism Category | Human |
| Pfam Domains | PF00001 (7tm_1) |
Summary
- Multi-target molecules 696
- Clinical molecules 1
- Avg pChEMBL 8.2
KEGG Pathways (17)
- AGE-RAGE signaling pathway in diabetic complications
- Adrenergic signaling in cardiomyocytes
- Aldosterone synthesis and secretion
- Apelin signaling pathway
- Calcium signaling pathway
- Coronavirus disease - COVID-19
- Cortisol synthesis and secretion
- Cushing syndrome
- Diabetic cardiomyopathy
- Hormone signaling
- Neuroactive ligand-receptor interaction
- Pathways in cancer
- Phospholipase D signaling pathway
- Renin secretion
- Renin-angiotensin system
- Vascular smooth muscle contraction
- cGMP-PKG signaling pathway
Associated Diseases (2)
Active Molecules (696)
| InChIKey | pChEMBL | Type | Targets | Clinical | |
|---|---|---|---|---|---|
BRBKSPFRJQPDPQ
|
9.6 | IC50 | 2 | — | |
ZJONKXVVDYTTBD
|
9.6 | Kd | 2 | — | |
AHZXSVWCNDLJER
|
9.6 | Kd | 2 | — | |
CWWCXCYXJZGDSQ
|
9.6 | IC50 | 2 | — | |
JWYRIVABJXWPRG
|
9.5 | IC50 | 2 | — | |
DGXVMSJCVAIYLV
|
9.5 | IC50 | 2 | — | |
GKEUJIWSZBCQCW
|
9.5 | IC50 | 2 | — | |
KBOMALZRTSYMGE
|
9.5 | IC50 | 2 | — | |
KEBWZNUGMFJSIR
|
9.5 | Kd | 2 | — | |
LJUHMEDWYHTVAZ
|
9.5 | IC50 | 2 | — | |
LTHDVPBTMSEPHD
|
9.5 | IC50 | 2 | — | |
NUAAPYLDFINKEK
|
9.5 | IC50 | 2 | — | |
PBMSATXCNSGHNA
|
9.5 | IC50 | 2 | — | |
PQANJJYWLNAWSH
|
9.5 | IC50 | 2 | — | |
SYQCYTQBFYWWPW
|
9.5 | IC50 | 2 | — | |
UTDBQIGWTCMRTM
|
9.5 | IC50 | 2 | — | |
VRBPVOFTDKMURN
|
9.5 | IC50 | 2 | — | |
WUAPPFLHASLIBW
|
9.5 | IC50 | 2 | — | |
YBPQNSLERGQMTB
|
9.5 | IC50 | 2 | — | |
YFWXFHNZGKNDBC
|
9.5 | IC50 | 2 | — | |
IPOVDWHRUSDRKN
|
9.5 | IC50 | 2 | — | |
YLFAFCSDNLBEIN
|
9.5 | IC50 | 2 | — | |
ATVSSVJXPQDMPF
|
9.5 | IC50 | 2 | — | |
XWUGQDJDBLWELV
|
9.5 | IC50 | 2 | — | |
JSIOYLLLTSFGGX
|
9.4 | IC50 | 2 | — | |
SVFINWJPPDSGLB
|
9.4 | IC50 | 2 | — | |
BQUFIDVGYDHRKS
|
9.4 | Kd | 2 | — | |
GEUPXOVRFJSXDQ
|
9.4 | IC50 | 2 | — | |
GYKVTFQQIXNTGJ
|
9.4 | IC50 | 2 | — | |
PFGWGEPQIUAZME
|
9.4 | IC50 | 2 | — | |
QLLMJWABIZKFMU
|
9.4 | IC50 | 2 | — | |
RGSWLSVTRUVUDY
|
9.4 | IC50 | 2 | — | |
WHZCAWQONQHVKL
|
9.4 | IC50 | 2 | — | |
XIENNQKFBNHYTB
|
9.4 | IC50 | 2 | — | |
XMZLTEXZGOCLFC
|
9.4 | IC50 | 2 | — | |
YWIJHCDHJCZLFM
|
9.4 | IC50 | 2 | — | |
DIKNHFNGFPAMID
|
9.4 | IC50 | 2 | — | |
CBZJAIIBBLGLCU
|
9.4 | Kd | 2 | — | |
IITNFWMVJHMXOV
|
9.4 | IC50 | 2 | — | |
FLXDMWLJSWWEJF
|
9.3 | IC50 | 2 | — | |
HGKMEGXYIQVEIT
|
9.3 | IC50 | 2 | — | |
NFWQZSLSBTWRGP
|
9.3 | IC50 | 2 | — | |
WASQCAWSXGBIRX
|
9.3 | IC50 | 2 | — | |
HUYZFSOAXSLWIU
|
9.3 | IC50 | 2 | — | |
MKVBRDKUMBQNQV
|
9.3 | IC50 | 2 | — | |
UTHMGJDXHJNITH
|
9.3 | IC50 | 2 | — | |
KYIGOCCCBXRHNJ
|
9.3 | IC50 | 43 | — | |
ANYZBXXMSODYCE
|
9.3 | IC50 | 2 | — | |
GZYGFQFOMPTHIF
|
9.3 | IC50 | 2 | — | |
JMZRIZSUJUOBIC
|
9.3 | Kd | 2 | — |